These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 31829928

  • 21. Evaluation of renal clinicopathological changes in IgA nephropathy by urinary podocytes excretion and podocalyxin expression.
    Jiang WL, Peng YM, Liu YH, Liu H, Chen GC, Xu XQ, Zhu XJ, Liu FY.
    Ren Fail; 2012; 34(7):821-6. PubMed ID: 22679920
    [Abstract] [Full Text] [Related]

  • 22. The urine albumin-to-creatinine ratio is a reliable indicator for evaluating complications of chronic kidney disease and progression in IgA nephropathy in China.
    Huan L, Yuezhong L, Chao W, HaiTao T.
    Clinics (Sao Paulo); 2016 May; 71(5):243-50. PubMed ID: 27276392
    [Abstract] [Full Text] [Related]

  • 23. Does circulating erythropoietin reflect progression of IgA nephropathy? Comparison with urinary N-acetyl-beta-D-glucosaminidase.
    Machiguchi T, Yoshida H, Yonemoto S, Minakata T, Nomura K, Muso E, Tamura T, Sasayama S.
    Nephrol Dial Transplant; 1999 Mar; 14(3):635-40. PubMed ID: 10193812
    [Abstract] [Full Text] [Related]

  • 24. Effect of Sevelamer on Serum Levels of Klotho and Soluble Tumor Necrosis Factor-like Weak Inducer of Apoptosis in Rats With Adenine-induced Chronic Kidney Disease.
    Golmohamadi Z, Argani H, Ghorbanihaghjo A, Rashtchizadeh N, Bargahi N, Mesgari M, Sanajou D.
    Iran J Kidney Dis; 2018 Oct; 12(5):281-287. PubMed ID: 30367019
    [Abstract] [Full Text] [Related]

  • 25. Urinary TWEAK level as a marker of lupus nephritis activity in 46 cases.
    Xuejing Z, Jiazhen T, Jun L, Xiangqing X, Shuguang Y, Fuyou L.
    J Biomed Biotechnol; 2012 Oct; 2012():359647. PubMed ID: 22719208
    [Abstract] [Full Text] [Related]

  • 26. Association between serum albumin level and incidence of end-stage renal disease in patients with Immunoglobulin A nephropathy: A possible role of albumin as an antioxidant agent.
    Kawai Y, Masutani K, Torisu K, Katafuchi R, Tanaka S, Tsuchimoto A, Mitsuiki K, Tsuruya K, Kitazono T.
    PLoS One; 2018 Oct; 13(5):e0196655. PubMed ID: 29795559
    [Abstract] [Full Text] [Related]

  • 27. Serum pentraxin-3 and tumor necrosis factor-like weak inducer of apoptosis (TWEAK) predict severity of infections in acute decompensated cirrhotic patients.
    Fan WC, Huang CC, Yang YY, Lin A, Lee KC, Hsieh YC, Fung CP, Hsu HC, Hou MC, Lin HC.
    J Microbiol Immunol Infect; 2017 Dec; 50(6):905-914. PubMed ID: 26872435
    [Abstract] [Full Text] [Related]

  • 28. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
    Bazzi C, Rizza V, Casellato D, Stivali G, Rachele G, Napodano P, Olivieri G, Gallieni M, D'Amico G.
    J Nephrol; 2012 Dec; 25(5):810-8. PubMed ID: 22252844
    [Abstract] [Full Text] [Related]

  • 29. The level of urinary secretory immunoglobulin A (sIgA) of patients with IgA nephropathy is elevated and associated with pathological phenotypes.
    Tan Y, Zhang JJ, Liu G, Zhang H, Zhao MH.
    Clin Exp Immunol; 2009 Apr; 156(1):111-6. PubMed ID: 19196254
    [Abstract] [Full Text] [Related]

  • 30. Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease.
    Bozic M, Méndez-Barbero N, Gutiérrez-Muñoz C, Betriu A, Egido J, Fernández E, Martín-Ventura JL, Valdivielso JM, Blanco-Colio LM, investigators from the NEFRONA study.
    Atherosclerosis; 2018 Mar; 270():13-20. PubMed ID: 29407881
    [Abstract] [Full Text] [Related]

  • 31. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
    Dong J, Peng T, Gao J, Jia X, Yan G, Wang Y.
    BMC Immunol; 2018 Jun 20; 19(1):18. PubMed ID: 29925312
    [Abstract] [Full Text] [Related]

  • 32. Tumor necrosis factor-like weak inducer of apoptosis induces inflammation in Graves' orbital fibroblasts.
    Lee SJ, Kim J, Ko J, Lee EJ, Koh HJ, Yoon JS.
    PLoS One; 2018 Jun 20; 13(12):e0209583. PubMed ID: 30576385
    [Abstract] [Full Text] [Related]

  • 33. The product of duration and amount of proteinuria (proteinuria index) is a possible marker for glomerular and tubulointerstitial damage in IgA nephropathy.
    Eiro M, Katoh T, Kuriki M, Asano K, Watanabe K, Watanabe T.
    Nephron; 2002 Apr 20; 90(4):432-41. PubMed ID: 11961402
    [Abstract] [Full Text] [Related]

  • 34. Urinary kidney injury molecule-1 in patients with IgA nephropathy is closely associated with disease severity.
    Xu PC, Zhang JJ, Chen M, Lv JC, Liu G, Zou WZ, Zhang H, Zhao MH.
    Nephrol Dial Transplant; 2011 Oct 20; 26(10):3229-36. PubMed ID: 21402675
    [Abstract] [Full Text] [Related]

  • 35. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
    Liang S, Cai GY, Duan ZY, Liu SW, Wu J, Lv Y, Hou K, Li ZX, Zhang XG, Chen XM.
    BMC Nephrol; 2017 Feb 15; 18(1):63. PubMed ID: 28201996
    [Abstract] [Full Text] [Related]

  • 36. Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
    Suzuki H, Allegri L, Suzuki Y, Hall S, Moldoveanu Z, Wyatt RJ, Novak J, Julian BA.
    Dis Markers; 2016 Feb 15; 2016():7806438. PubMed ID: 27647947
    [Abstract] [Full Text] [Related]

  • 37. Urinary angiotensinogen as a predictive marker in patients with immunoglobulin A nephropathy.
    Kim YG, Song SB, Lee SH, Moon JY, Jeong KH, Lee TW, Ihm CG.
    Clin Exp Nephrol; 2011 Oct 15; 15(5):720-726. PubMed ID: 21695414
    [Abstract] [Full Text] [Related]

  • 38. Urine TWEAK level as a biomarker for early response to treatment in active lupus nephritis: a prospective multicentre study.
    Suttichet TB, Kittanamongkolchai W, Phromjeen C, Anutrakulchai S, Panaput T, Ingsathit A, Kamanamool N, Ophascharoensuk V, Sumethakul V, Avihingsanon Y.
    Lupus Sci Med; 2019 Oct 15; 6(1):e000298. PubMed ID: 31168397
    [Abstract] [Full Text] [Related]

  • 39. Serum levels of tumor necrosis factor alpha in patients with IgA nephropathy are closely associated with disease severity.
    Li G, Wu W, Zhang X, Huang Y, Wen Y, Li X, Gao R.
    BMC Nephrol; 2018 Nov 14; 19(1):326. PubMed ID: 30428849
    [Abstract] [Full Text] [Related]

  • 40. Serum soluble TWEAK levels in severe traumatic brain injury and its prognostic significance.
    Tang B, Zhong Z, Qiu Z, Wu HP, Hu JY, Ma JP, Wu JP.
    Clin Chim Acta; 2019 Aug 14; 495():227-232. PubMed ID: 31009601
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.